Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Return on Equity (2019 - 2025)

Korro Bio's Return on Equity history spans 7 years, with the latest figure at 0.01% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 50.0% year-over-year to 0.01%, compared with a TTM value of 0.01% through Dec 2025, up 50.0%, and an annual FY2025 reading of 0.01%, up 51.0% over the prior year.
  • Return on Equity for Q4 2025 was 0.01% at Korro Bio, up from 0.83% in the prior quarter.
  • The five-year high for Return on Equity was 6.8% in Q4 2022, with the low at 9.75% in Q4 2023.
  • Average Return on Equity over 5 years is 0.64%, with a median of 0.49% recorded in 2024.
  • Year-over-year, Return on Equity tumbled -1655bps in 2023 and then surged 926bps in 2024.
  • Tracing KRRO's Return on Equity over 5 years: stood at 1.61% in 2021, then skyrocketed by 521bps to 6.8% in 2022, then plummeted by -243bps to 9.75% in 2023, then skyrocketed by 95bps to 0.49% in 2024, then surged by 102bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Return on Equity are 0.01% (Q4 2025), 0.83% (Q3 2025), and 0.72% (Q2 2025).